Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment (HEART)

Complete Title: ALTE11C2, Health Effects after Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-related Cardiomyopathy

Trial Phase: N/A

Investigator: Eric Chow

This clinical trial studies the effects of dexrazoxane hydrochloride on biomarkers associated with cardiomyopathy and heart failure after cancer treatment. Studying samples of blood in the laboratory from patients receiving dexrazoxane hydrochloride may help doctors learn more about the effects of dexrazoxane hydrochloride on cells. It may also help doctors understand how well patients respond to treatment.

Keywords:

Hematologic Malignancies
Lymphoma, Hodgkin
Leukemia
Lymphoma
Lymphoproliferative Disorders
Pediatric Cancers, Miscellaneous
Neoplasms
Leukemia, Lymphoid
Immunoproliferative Disorders
Cardiovascular Diseases
Leukemia, T-Cell
Immune System Diseases
Cardiomyopathies

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.